1
|
Bacterial cytotoxins: targeting eukaryotic switches.
|
Nat Rev Microbiol
|
2005
|
1.98
|
2
|
An in vitro and in vivo disconnect uncovered through high-throughput identification of botulinum neurotoxin A antagonists.
|
Proc Natl Acad Sci U S A
|
2007
|
1.85
|
3
|
Synthesis, characterization and development of a high-throughput methodology for the discovery of botulinum neurotoxin a inhibitors.
|
J Comb Chem
|
2006
|
1.79
|
4
|
Pseudomonas aeruginosa ExoT ADP-ribosylates CT10 regulator of kinase (Crk) proteins.
|
J Biol Chem
|
2003
|
1.60
|
5
|
Unique substrate recognition by botulinum neurotoxins serotypes A and E.
|
J Biol Chem
|
2006
|
1.54
|
6
|
The C-terminus of botulinum neurotoxin type A light chain contributes to solubility, catalysis, and stability.
|
Protein Expr Purif
|
2004
|
1.45
|
7
|
Glycosylated SV2 and gangliosides as dual receptors for botulinum neurotoxin serotype F.
|
Biochemistry
|
2009
|
1.41
|
8
|
Subunit vaccine against the seven serotypes of botulism.
|
Infect Immun
|
2007
|
1.39
|
9
|
Molecular mechanisms of the cytotoxicity of ADP-ribosylating toxins.
|
Annu Rev Microbiol
|
2008
|
1.35
|
10
|
In vivo rho GTPase-activating protein activity of Pseudomonas aeruginosa cytotoxin ExoS.
|
Infect Immun
|
2002
|
1.35
|
11
|
Mechanism of substrate recognition by botulinum neurotoxin serotype A.
|
J Biol Chem
|
2007
|
1.30
|
12
|
Intracellular localization modulates targeting of ExoS, a type III cytotoxin, to eukaryotic signalling proteins.
|
Mol Microbiol
|
2002
|
1.17
|
13
|
Auto-ADP-ribosylation of Pseudomonas aeruginosa ExoS.
|
J Biol Chem
|
2002
|
1.16
|
14
|
Botulinum neurotoxin A protease: discovery of natural product exosite inhibitors.
|
J Am Chem Soc
|
2010
|
1.14
|
15
|
Intracellular membrane localization of pseudomonas ExoS and Yersinia YopE in mammalian cells.
|
J Biol Chem
|
2003
|
1.14
|
16
|
Association of botulinum neurotoxin serotypes a and B with synaptic vesicle protein complexes.
|
Biochemistry
|
2007
|
1.14
|
17
|
Discovery and structural characterization of a small molecule 14-3-3 protein-protein interaction inhibitor.
|
Proc Natl Acad Sci U S A
|
2011
|
1.12
|
18
|
Gangliosides as high affinity receptors for tetanus neurotoxin.
|
J Biol Chem
|
2009
|
1.12
|
19
|
Substrate recognition of VAMP-2 by botulinum neurotoxin B and tetanus neurotoxin.
|
J Biol Chem
|
2008
|
1.11
|
20
|
Multiple pocket recognition of SNAP25 by botulinum neurotoxin serotype E.
|
J Biol Chem
|
2007
|
1.10
|
21
|
Characterization of the antibody response to the receptor binding domain of botulinum neurotoxin serotypes A and E.
|
Infect Immun
|
2005
|
1.10
|
22
|
Recombinant holotoxoid vaccine against botulism.
|
Infect Immun
|
2007
|
1.09
|
23
|
Botulinum neurotoxin subtype A2 enters neuronal cells faster than subtype A1.
|
FEBS Lett
|
2010
|
1.07
|
24
|
Ezrin/radixin/moesin proteins are high affinity targets for ADP-ribosylation by Pseudomonas aeruginosa ExoS.
|
J Biol Chem
|
2004
|
1.05
|
25
|
How bacterial ADP-ribosylating toxins recognize substrates.
|
Nat Struct Mol Biol
|
2004
|
1.04
|
26
|
Light chain of botulinum neurotoxin serotype A: structural resolution of a catalytic intermediate.
|
Biochemistry
|
2006
|
1.04
|
27
|
Uncoupling Crk signal transduction by Pseudomonas exoenzyme T.
|
J Biol Chem
|
2005
|
1.03
|
28
|
The ADP-ribosylation domain of Pseudomonas aeruginosa ExoS is required for membrane bleb niche formation and bacterial survival within epithelial cells.
|
Infect Immun
|
2010
|
1.03
|
29
|
ADP-ribosylation and functional effects of Pseudomonas exoenzyme S on cellular RalA.
|
Biochemistry
|
2002
|
1.02
|
30
|
Identification of a unique ganglioside binding loop within botulinum neurotoxins C and D-SA .
|
Biochemistry
|
2010
|
1.01
|
31
|
Intracellular localization of type III-delivered Pseudomonas ExoS with endosome vesicles.
|
J Biol Chem
|
2007
|
1.01
|
32
|
Catalytic properties of botulinum neurotoxin subtypes A3 and A4.
|
Biochemistry
|
2009
|
0.99
|
33
|
Chirality holds the key for potent inhibition of the botulinum neurotoxin serotype a protease.
|
Org Lett
|
2010
|
0.99
|
34
|
A leucine-rich motif targets Pseudomonas aeruginosa ExoS within mammalian cells.
|
Infect Immun
|
2005
|
0.99
|
35
|
Children with cystic fibrosis produce an immune response against exoenzyme S, a type III cytotoxin of Pseudomonas aeruginosa.
|
J Infect Dis
|
2002
|
0.98
|
36
|
Tetanus toxin and botulinum toxin a utilize unique mechanisms to enter neurons of the central nervous system.
|
Infect Immun
|
2012
|
0.97
|
37
|
Modulation of host cell endocytosis by the type III cytotoxin, Pseudomonas ExoS.
|
Traffic
|
2008
|
0.96
|
38
|
Molecular basis for tetanus toxin coreceptor interactions.
|
Biochemistry
|
2008
|
0.96
|
39
|
Vaccines against botulism.
|
Curr Opin Microbiol
|
2012
|
0.96
|
40
|
ExoS Rho GTPase-activating protein activity stimulates reorganization of the actin cytoskeleton through Rho GTPase guanine nucleotide disassociation inhibitor.
|
J Biol Chem
|
2004
|
0.95
|
41
|
Engineering botulinum neurotoxin to extend therapeutic intervention.
|
Proc Natl Acad Sci U S A
|
2009
|
0.95
|
42
|
Botulinum neurotoxin B-host receptor recognition: it takes two receptors to tango.
|
Nat Struct Mol Biol
|
2007
|
0.93
|
43
|
Association of botulinum neurotoxin serotype A light chain with plasma membrane-bound SNAP-25.
|
J Biol Chem
|
2011
|
0.91
|
44
|
Benzylidene cyclopentenediones: First irreversible inhibitors against botulinum neurotoxin A's zinc endopeptidase.
|
Bioorg Med Chem Lett
|
2009
|
0.90
|
45
|
Structural analysis of botulinum neurotoxin type G receptor binding .
|
Biochemistry
|
2010
|
0.90
|
46
|
Plasma membrane localization affects the RhoGAP specificity of Pseudomonas ExoS.
|
Cell Microbiol
|
2007
|
0.89
|
47
|
Novel ganglioside-mediated entry of botulinum neurotoxin serotype D into neurons.
|
J Biol Chem
|
2011
|
0.89
|
48
|
Identification of a Natural Product Antagonist against the Botulinum Neurotoxin Light Chain Protease.
|
ACS Med Chem Lett
|
2010
|
0.89
|
49
|
Pseudomonas aeruginosa ExoS ADP-ribosyltransferase inhibits ERM phosphorylation.
|
Cell Microbiol
|
2006
|
0.89
|
50
|
Insights into the different catalytic activities of Clostridium neurotoxins.
|
Biochemistry
|
2012
|
0.89
|
51
|
Botulinum neurotoxin serotype C associates with dual ganglioside receptors to facilitate cell entry.
|
J Biol Chem
|
2012
|
0.88
|
52
|
Membrane localization contributes to the in vivo ADP-ribosylation of Ras by Pseudomonas aeruginosa ExoS.
|
Infect Immun
|
2002
|
0.88
|
53
|
Toxins from bacteria.
|
EXS
|
2010
|
0.87
|
54
|
Synthetic substrate for application in both high and low throughput assays for botulinum neurotoxin B protease inhibitors.
|
Bioorg Med Chem Lett
|
2009
|
0.85
|
55
|
Association of botulinum neurotoxins with synaptic vesicle protein complexes.
|
Toxicon
|
2009
|
0.85
|
56
|
Intracellular trafficking of Pseudomonas ExoS, a type III cytotoxin.
|
Traffic
|
2007
|
0.85
|
57
|
The C-terminus of Botulinum A Protease Has Profound and Unanticipated Kinetic Consequences Upon the Catalytic Cleft.
|
ACS Med Chem Lett
|
2012
|
0.84
|
58
|
Adenylate cyclase activity of Pseudomonas aeruginosa ExoY can mediate bleb-niche formation in epithelial cells and contributes to virulence.
|
Microb Pathog
|
2011
|
0.84
|
59
|
The chaperone protein SmgGDS interacts with small GTPases entering the prenylation pathway by recognizing the last amino acid in the CAAX motif.
|
J Biol Chem
|
2014
|
0.83
|
60
|
Entry of a recombinant, full-length, atoxic tetanus neurotoxin into Neuro-2a cells.
|
Infect Immun
|
2013
|
0.83
|
61
|
General aspects and recent advances on bacterial protein toxins.
|
Cold Spring Harb Perspect Med
|
2013
|
0.83
|
62
|
Subunit vaccine efficacy against Botulinum neurotoxin subtypes.
|
Vaccine
|
2011
|
0.81
|
63
|
Enhancing the protective immune response against botulism.
|
Infect Immun
|
2013
|
0.81
|
64
|
Molecular heterogeneity of a type III cytotoxin, Pseudomonas aeruginosa exoenzyme S.
|
Biochemistry
|
2003
|
0.81
|
65
|
Proteomic identification of OprL as a seromarker for initial diagnosis of Pseudomonas aeruginosa infection of patients with cystic fibrosis.
|
J Clin Microbiol
|
2009
|
0.80
|
66
|
Host cell cytotoxicity and cytoskeleton disruption by CerADPr, an ADP-ribosyltransferase of Bacillus cereus G9241.
|
Biochemistry
|
2013
|
0.79
|
67
|
Pseudomonas aeruginosa utilizes the type III secreted toxin ExoS to avoid acidified compartments within epithelial cells.
|
PLoS One
|
2013
|
0.79
|
68
|
Unique ganglioside binding by botulinum neurotoxins C and D-SA.
|
FEBS J
|
2011
|
0.78
|
69
|
Exoenzyme S ADP-ribosylates Rab5 effector sites to uncouple intracellular trafficking.
|
Infect Immun
|
2013
|
0.78
|
70
|
Expression and purification of two recombinant forms of the type-III cytotoxin, Pseudomonas aeruginosa ExoS.
|
Protein Expr Purif
|
2002
|
0.78
|
71
|
Bacillus cereus Certhrax ADP-ribosylates vinculin to disrupt focal adhesion complexes and cell adhesion.
|
J Biol Chem
|
2014
|
0.76
|
72
|
Multiple domains of tetanus toxin direct entry into primary neurons.
|
Traffic
|
2014
|
0.75
|